Sarah Elkourashy: Venous Thromboembolism in Pregnancy
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, shared on LinkedIn:
”Venous Thromboembolism in Pregnancy: Diagnostic Challenges and Evolving Best Practices
My recent article in the NCCCR Newsletter (November 2025) discusses the complexities surrounding venous thromboembolism (VTE); a major contributor to maternal morbidity and mortality worldwide.
Pregnancy induces a hypercoagulable state, increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) by up to 4-6 times compared with non-pregnant women. Diagnostic evaluation remains challenging due to overlapping physiological symptoms, limitations of clinical scoring systems, and lack of universally accepted diagnostic algorithms.
The article highlights recent advances in imaging, which now offers rapid, reliable imaging with significantly reduced radiation exposure. The importance of informed patient counseling during diagnostic evaluation is underscored, ensuring women understand both the clinical necessity and safety of imaging investigations.
Effective management of VTE in pregnancy requires multidisciplinary collaboration among hematology, obstetrics, radiology, anesthesia, and maternal-fetal medicine teams. A patient-centered approach that combines timely diagnosis, evidence-based prophylaxis, and empathetic communication is central to improving maternal outcomes.
Read the full article in the NCCCR Newsletter, November 2025.”
Title: Venous Thromboembolism in Pregnancy
Author: Sarah Elkourashy

Stay updated with Hemostasis Today.
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care